fbpx
Learn2Health: Learn about Diabetes and Healthy Meal Planning

New study for those with heart disease and excess weight

About The Study

 

This study is for people living with obesity and heart disease. Participants will start either a once weekly injection of CagriSema or placebo to their current treatment. CagriSema is a combination medication of Cagrilinitide and Semaglutide. Cagrilinitide is an investigational once-weekly injection, and Semaglutide is an FDA approved once-weekly injection (Ozempic).

The goal of the study is to assess the safety of CagriSema in people living with obesity and cardiovascular disease.

Participants will receive the study med at no charge, and will be compensated for their time and travel.

To take part in the study, participants should be:

  • 55 years of age and older
  • Have obesity
  • History of heart attack, stroke or arterial disease

See if you qualify
Study Image

What Is a Study?

  • A clinical study helps advance the future of diabetes! Research patients try new meds or devices not yet available to the public, at no cost to them.
  • Research patients meet with a study coordinator and doctor multiple times to monitor them.
  • Each visit, patients are compensated for travel expenses.
  • Study patients must meet a list of criteria in order to be a part of a study.
  • A study can last anywhere from six months to a few years.

Join this study!

If you want to see if you qualify for a study, share your information and we will contact you. Want to speak with someone immediately? Call (515) 329-5690.

Please enter your first name.
Please enter your last name.
Please enter a valid phone number.
Please enter a valid email address.

Benefits


Receive free medications and free supplies!

Gain better understanding of your disease and take an active role in your health.

Obtain treatments not yet available and contribute to medical research.

Travel stipends for attending most scheduled research appointments.

On average patients receives free care worth $250 - $500 from diabetes experts.

So far Iowa Diabetes Research has spent more than $500K on patients benefits

Our Caring Team

Anuj Bhargava

Dr. Anuj Bhargava

CEO and Medical Director

Christine Burke

Christine Burke

Director of Clinical Services

Tara Herrold

Tara Herrold

Director of Clinical Research

Lisa Borg

Lisa Borg

Clinical Research Coordinator

Natalie Young

Natalie Young

Clinical Research Coordinator

Kendra Ridenour

Kendra Ridenour

Navigator/Study Start-up Manager

Kara Turner

Kara Turner

Clinical Research Coordinator

Allie Fowler

Allie Bohr

Clinical Research Coordinator

Have questions?

Call us at (515) 329-6800

Email us at info@iowadiabetes.com.